NU2RGH001916
Cooperative Agreement
Overview
Grant Description
Task Force for Global Health Support to Capacity Building for Global, Regional, and National Immunization Programs
Since the Global Polio Eradication Initiative was established in 1988, more than 2.5 billion children have been immunized against polio. Worldwide eradication efforts have seen the number of reported cases of wild poliovirus (WPV) decrease by more than 99 percent. Today, polio remains endemic in only two countries: Afghanistan and Pakistan.
The insidious spread of this highly contagious disease highlights the importance of maintaining a network of highly trained professionals with expertise in public health surveillance and applied epidemiology. Ministries of Health require increased support during disease outbreaks and eradication campaigns.
With polio outbreaks occurring in other key focal areas due to circulating type 2 vaccine-derived poliovirus (cVDPV2) in Cote d'Ivoire, Liberia, Sudan, Tajikistan, and Niger, with the risk of further outbreaks in the Lake Chad Basin remaining high, provision of targeted in-country surveillance and response through surge support has become an important tool in the fight to eradicate polio.
The resurgence of other vaccine-preventable diseases (VPD) such as measles further supports the need to strengthen routine immunization systems in VPD outbreak countries. It is also important to support the development of tools, guidance, and advisory groups to enhance the effectiveness of global immunization programs.
The considerable progress achieved over the past decades to eradicate polio, eliminate measles and rubella, and control other VPDS including typhoid, hepatitis B, cholera, and neonatal tetanus through strengthened immunization systems at the global, regional, and national level has been put at risk due to the outbreak of coronavirus disease (COVID-19).
It is within this context that the Task Force for Global Health proposes to engage its experience and expertise to eliminate the threat of VPDS by building country, regional, and global immunization capacity to prevent, detect, and respond to VPDS. This requires strengthened and expanded surveillance activities and rapid, targeted outbreak response.
Our overarching purpose is to utilize the extensive resources and experience of the Task Force for Global Health to build the capacity of national, regional, and global immunization programs to eliminate the threat of VPDS, particularly polio, worldwide. Within the Task Force for Global Health, the TEPHINET program and the Center for Vaccine Equity will advance the key strategies listed in the CDC NOFO. We will scale up the successful programs that we implemented during the previous COAG and establish new programs to further build regional, national, and global capacity to eliminate VPDS.
TEPHINET will improve vaccination coverage percentages in high-risk and special populations by continuing to build critical skills related to routine immunization delivery, immunization campaigns, and surveillance and outbreak response in Pakistan and other high-priority countries. This will be achieved through activities including NSTOP Pakistan, Afghanistan Immunization Systems Strengthening, and the Strengthening Surveillance and Immunizations Systems Project. TEPHINET support will also focus on measles rapid diagnostic testing and the development of surveillance software tools to improve measles outbreak response in Africa, Southeast Asia, and Brazil.
CVE's implementation of the Polio Eradication Global Outbreak Response Activity will continue to improve cVDPV2 outbreak responses and surveillance capacity. CVE will lead and convene immunization coalitions and strengthen global NITAG capacity through its US Coalition on Global Immunization, Coalition for Global Hepatitis Elimination, and NITAG activities.
The Brighton Collaboration team will work to strengthen global immunization safety monitoring systems. The Task Force's in-house technical capacity, combined with existing program and FETP network relationships, are strong assets in achieving these goals.
Since the Global Polio Eradication Initiative was established in 1988, more than 2.5 billion children have been immunized against polio. Worldwide eradication efforts have seen the number of reported cases of wild poliovirus (WPV) decrease by more than 99 percent. Today, polio remains endemic in only two countries: Afghanistan and Pakistan.
The insidious spread of this highly contagious disease highlights the importance of maintaining a network of highly trained professionals with expertise in public health surveillance and applied epidemiology. Ministries of Health require increased support during disease outbreaks and eradication campaigns.
With polio outbreaks occurring in other key focal areas due to circulating type 2 vaccine-derived poliovirus (cVDPV2) in Cote d'Ivoire, Liberia, Sudan, Tajikistan, and Niger, with the risk of further outbreaks in the Lake Chad Basin remaining high, provision of targeted in-country surveillance and response through surge support has become an important tool in the fight to eradicate polio.
The resurgence of other vaccine-preventable diseases (VPD) such as measles further supports the need to strengthen routine immunization systems in VPD outbreak countries. It is also important to support the development of tools, guidance, and advisory groups to enhance the effectiveness of global immunization programs.
The considerable progress achieved over the past decades to eradicate polio, eliminate measles and rubella, and control other VPDS including typhoid, hepatitis B, cholera, and neonatal tetanus through strengthened immunization systems at the global, regional, and national level has been put at risk due to the outbreak of coronavirus disease (COVID-19).
It is within this context that the Task Force for Global Health proposes to engage its experience and expertise to eliminate the threat of VPDS by building country, regional, and global immunization capacity to prevent, detect, and respond to VPDS. This requires strengthened and expanded surveillance activities and rapid, targeted outbreak response.
Our overarching purpose is to utilize the extensive resources and experience of the Task Force for Global Health to build the capacity of national, regional, and global immunization programs to eliminate the threat of VPDS, particularly polio, worldwide. Within the Task Force for Global Health, the TEPHINET program and the Center for Vaccine Equity will advance the key strategies listed in the CDC NOFO. We will scale up the successful programs that we implemented during the previous COAG and establish new programs to further build regional, national, and global capacity to eliminate VPDS.
TEPHINET will improve vaccination coverage percentages in high-risk and special populations by continuing to build critical skills related to routine immunization delivery, immunization campaigns, and surveillance and outbreak response in Pakistan and other high-priority countries. This will be achieved through activities including NSTOP Pakistan, Afghanistan Immunization Systems Strengthening, and the Strengthening Surveillance and Immunizations Systems Project. TEPHINET support will also focus on measles rapid diagnostic testing and the development of surveillance software tools to improve measles outbreak response in Africa, Southeast Asia, and Brazil.
CVE's implementation of the Polio Eradication Global Outbreak Response Activity will continue to improve cVDPV2 outbreak responses and surveillance capacity. CVE will lead and convene immunization coalitions and strengthen global NITAG capacity through its US Coalition on Global Immunization, Coalition for Global Hepatitis Elimination, and NITAG activities.
The Brighton Collaboration team will work to strengthen global immunization safety monitoring systems. The Task Force's in-house technical capacity, combined with existing program and FETP network relationships, are strong assets in achieving these goals.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Place of Performance
Georgia
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
COVID-19 $24,960,369 (35%) percent of this Cooperative Agreement was funded by COVID-19 emergency acts including the American Rescue Plan Act of 2021 and the CARES Act.
Amendment Since initial award the total obligations have increased 2300% from $2,996,572 to $71,922,769.
Amendment Since initial award the total obligations have increased 2300% from $2,996,572 to $71,922,769.
The Task Force For Global Health was awarded
Global Immunization Capacity Building Support
Cooperative Agreement NU2RGH001916
worth $71,922,769
from National Center for Emerging and Zoonotic Infectious Diseases in August 2021 with work to be completed primarily in Georgia United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.283 Centers for Disease Control and Prevention Investigations and Technical Assistance.
The Cooperative Agreement was awarded through grant opportunity Capacity Building for Global, Regional, and National Immunization Programs.
Status
(Ongoing)
Last Modified 8/6/25
Period of Performance
8/1/21
Start Date
7/31/26
End Date
Funding Split
$71.9M
Federal Obligation
$0.0
Non-Federal Obligation
$71.9M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for NU2RGH001916
Transaction History
Modifications to NU2RGH001916
Additional Detail
Award ID FAIN
NU2RGH001916
SAI Number
NU2RGH001916-3732743671
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CVL0 CDC NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES
Awardee UEI
L9DLXYHZ3TM8
Awardee CAGE
3L9S3
Performance District
GA-90
Senators
Jon Ossoff
Raphael Warnock
Raphael Warnock
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| CDC-Wide Activities and Program Support, Centers for Disease Control and Prevention, Health and Human Services (075-0943) | Health care services | Grants, subsidies, and contributions (41.0) | $24,960,369 | 62% |
| Global Health, Centers for Disease Control and Prevention, Health and Human Services (075-0955) | Health care services | Grants, subsidies, and contributions (41.0) | $15,333,553 | 38% |
Modified: 8/6/25